Neutral impactStocks
Neuland Labs' first commercial peptide manufacturing module goes operational; Stock sees profit booking
CNBC-TV18 1 hr ago·15 Sept 2026, 7:10 am
Neuland Labs' second module is planned to have a total reactor capacity of up to 18,000 litres. It will include three 5,000-litre LPPS reactors, either a 1,000-litre or 2,000-litre SPPS reactor, and smaller reactors of up to 1,000 litres.
Key takeaways
- Category: Stocks.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
